No Data
Organogenesis Hldgs Q1 2024 Adj EPS $(0.01) Beats $(0.03) Estimate, Sales $109.976M Beat $101.050M Estimate
Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66.67 percent. This is unchanged from the same period last year
Express News | Organogenesis Holdings Inc: Reaffirming Prior Guidance for 2024
Express News | Organogenesis Holdings Inc: Qtrly Shr Loss $0.02
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, Vs. Street Est of $101.1M
04:31 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M
Organogenesis | 10-Q: Quarterly report
Express News | Organogenesis Outlook FY Ebitda USD 5.8-25 Million